UCT1072s, new antitumor antibiotics with topoisomerase II mediated DNA cleavage activity, from Aspergillus sp.
Asai
A
A
Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan.
Yamashita
Y
Y
Ando
K
K
Kakita
S
S
Kita
K
K
Suzuki
Y
Y
Mihara
A
A
Ashizawa
T
T
Mizukami
T
T
Nakano
H
H
D000880:Anthraquinones / Q000302:isolation & purification* / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000302:isolation & purification* / Q000494:pharmacology; D001230:Aspergillus / Q000378:metabolism*; D004249:DNA Damage; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005285:Fermentation; D005663:Furans / Q000302:isolation & purification* / Q000494:pharmacology; D006801:Humans; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured
D000880:Anthraquinones; D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D005663:Furans; D059005:Topoisomerase II Inhibitors; C403877:UCT 1072M1; C403878:UCT 1072M2